Pathways of cancer cell evolution
101 – 110 of 136
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
- Contribution to journal › Article
-
Mark
Extensive clonal branching shapes the evolutionary history of high-risk pediatric cancers
- Contribution to journal › Article
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
- Contribution to journal › Article
-
Mark
The Cellular Architectures of Hypospadias
- Contribution to journal › Letter
-
Mark
A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour
- Contribution to journal › Article
-
Mark
Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome
- Contribution to journal › Article
-
Mark
CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
- Contribution to journal › Article
